Literature DB >> 12741932

Prevalence of asthma and asthma action plans in South Australia: population surveys from 1990 to 2001.

David H Wilson1, Robert J Adams, Sarah L Appleton, Graeme Hugo, David Wilkinson, Janet Hiller, Philip Ryan, Julianne Cheek, Richard E Ruffin.   

Abstract

OBJECTIVES: To assess trends in the prevalence of self-reported doctor-diagnosed asthma, associated asthma related morbidity, and the uptake of written asthma action plans in South Australia, 1990-2001. DESIGN, SETTING AND PARTICIPANTS: Surveys by telephone interview of the South Australian population between 1990 and 2001, and interview of participants in their own homes by trained health interviewers. MAIN OUTCOME MEASURES: Asthma prevalence, percentage of patients with written action plans, and asthma associated morbidity.
RESULTS: The reported prevalence of doctor-diagnosed asthma has increased from 8% (95% CI, 6.4%-9.6%) in 1990 to 12.8% (95% CI, 11.4%-14.2%) in 2001. Morbidity, as measured by wakening at night (daily or weekly) and days lost from normal activities because of asthma, has remained constant over the decade. The percentage of patients with written asthma action plans increased to a peak of 42.3% (95% CI, 40.3%-44.3%) in 1995, but then declined to 22.2% (95% CI, 20.7%-23.7%) in 2001.
CONCLUSIONS: The prevalence of asthma has increased while morbidity has remained constant, indicating that the burden of asthma has increased. The associated decline in the percentage of patients with asthma action plans in recent years is cause for concern.

Entities:  

Mesh:

Year:  2003        PMID: 12741932     DOI: 10.5694/j.1326-5377.2003.tb05320.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  4 in total

1.  When can personal best peak flow be determined for asthma action plans?

Authors:  H K Reddel; G B Marks; C R Jenkins
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

2.  Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community.

Authors:  Carol Armour; Sinthia Bosnic-Anticevich; Martha Brillant; Debbie Burton; Lynne Emmerton; Ines Krass; Bandana Saini; Lorraine Smith; Kay Stewart
Journal:  Thorax       Date:  2007-01-24       Impact factor: 9.139

3.  Single-inhaler combination therapy for maintenance and relief of asthma: a new strategy in disease management.

Authors:  Matthew Peters
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations.

Authors:  P Kuna; M J Peters; A I Manjra; C Jorup; I P Naya; N E Martínez-Jimenez; R Buhl
Journal:  Int J Clin Pract       Date:  2007-03-16       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.